Recent data from our group are consistent with the crucial role played by SLiMs in the PPI network of SET and MYND domain containing 3 (SMYD3) in different cancer study models, including BC, CRC, and other gastrointestinal tumors [123,124]. This evidence concerns the gene SMYD3 and breast cancer.